News

October 26, 2016

Experimental Mesothelioma Therapy May Boost Tumor Immune Surveillance

News

ADI-PEG 20, a drug that depletes arginine from the body, is under clinical trials for a number of cancers, including mesothelioma, due to its strong anti-cancer activity. But a new ... Read more

October 25, 2016October 26, 2016

Yondelis, Derived from Sea Cucumber, Shows Promise for Malignant Pleural Mesothelioma

News

Yondelis (trabectedin), a drug derived from the Caribbean Sea cucumber, has shown promise for treating malignant pleural mesothelioma (MPM), according to a new study published in Molecular Cancer Therapeutics, the journal of ... Read more

October 24, 2016

Targeted Antibody Drugs Ineffective in Mesothelioma, Immuno-imaging Shows

News

Using immuno-imaging to assess whether a tumor is likely to react to therapies targeting mesothelin, which is over-expressed in certain cancers, researchers demonstrated that a cancer drug linked to a ... Read more

October 24, 2016

Questions to Ask Before Participating in a Mesothelioma Clinical Trial

News

There are several key questions that a participant will want answered before enrolling in a clinical trial. Many are listed here, but patients should feel free to ask study coordinators any additional questions they may ... Read more

October 21, 2016October 21, 2016

Sellas Life Sciences Names Jonathan Eckard as New Chief Business and Strategy Officer

News

Sellas Life Sciences recently named Jonathan Eckard, PhD, as its chief business and strategy officer. Eckard’s doctorate in toxicology and carcinogenesis is from NYU School of Medicine, where he also earned a master’s ... Read more

October 20, 2016

Potential Marker for Pleural Mesothelioma Identified, Improving Prognostic Accuracy

News

Researchers have identified a factor called glycodelin that may serve as a new marker for diagnosing malignant pleural mesothelioma (MPM) and monitoring tumor response to treatment during follow-up. The study, ... Read more

October 18, 2016

Molecule Seen to Aid Chemotherapy in Treating Malignant Pleural Mesothelioma

News

Researchers may have found a way to strengthen the effectiveness of chemotherapy in malignant pleural mesothelioma (MPM), according to a study published in Molecular Pharmaceuticals. The study, “Systemically Administered Rnai Molecule Sensitizes Malignant ... Read more

October 17, 2016May 16, 2017

Promising Approach Against Mesothelioma Involves Inhibiting 2 Proteins

News

Simultaneous inhibition of two proteins, FAK and MDM2, may have therapeutic applications against mesothelioma. A recent study showed that the proteins prevent malignant cells from activating mechanisms involved in cell death, and activate those involved ... Read more

October 16, 2016October 17, 2016

Mesothelioma Clinical Trials: Reasons to Participate

News

Clinical trials are extremely important scientific studies required by the U.S. Food and Drug Administration (FDA) to assess new medical treatments, including treatments for mesothelioma. There can be benefits for people ... Read more